Literature DB >> 10942865

Assessing the Saskatchewan database for outcomes research studies of depression and its treatment.

S L West1, A Richter, C A Melfi, M McNutt, M E Nennstiel, J A Mauskopf.   

Abstract

This study was conducted to evaluate the validity of using the Saskatchewan Health administrative claims databases for conducting depression research. To develop a claims-based definition of depression, we identified a cohort of individuals who began a "new" period of antidepressant use (no use 180 days prior) from which we selected a stratified random sample (n = 600) for medical record abstraction. The medical record diagnosis was used as the gold standard for judging our database definitions of depression. After defining a primary database definition of depression, we tried to refine it using medically probable scenarios and assessed refinement by agreement statistics. Defining depression with ICD9 codes 296 (affective disorders), 309 (adjustment reaction), and 311 (depressive disorders), the sensitivity (Se), specificity (Sp), positive (PV+) and negative predictive (PV-) values were: 71%, 85%, 86%, and 70%, respectively. Algorithms that limited the number of false-negatives resulted in: Se = 84% and PV- = 77% whereas those that limited false-positives resulted in: Sp = 90% and PV+ = 86%. Although our depression definition requires treatment with antidepressants, this definition will allow us to conduct future studies of depression and its treatment using the Saskatchewan Health databases.

Entities:  

Mesh:

Year:  2000        PMID: 10942865     DOI: 10.1016/s0895-4356(99)00237-1

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  15 in total

1.  Type 2 diabetes does not increase risk of depression.

Authors:  Lauren C Brown; Sumit R Majumdar; Stephen C Newman; Jeffrey A Johnson
Journal:  CMAJ       Date:  2006-07-04       Impact factor: 8.262

2.  Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants?

Authors:  Kristin Palmsten; Soko Setoguchi; Andrea V Margulis; Amanda R Patrick; Sonia Hernández-Díaz
Journal:  Am J Epidemiol       Date:  2012-03-22       Impact factor: 4.897

3.  Do contact precautions cause depression? A two-year study at a tertiary care medical centre.

Authors:  H R Day; E N Perencevich; A D Harris; S S Himelhoch; C H Brown; A L Gruber-Baldini; E Dotter; D J Morgan
Journal:  J Hosp Infect       Date:  2011-06-12       Impact factor: 3.926

4.  A Surveillance System to Monitor Excess Mortality of People With Mental Illness in Canada.

Authors:  Alain Lesage; Louis Rochette; Valérie Émond; Éric Pelletier; Danielle St-Laurent; Fatoumata Binta Diallo; Stephen Kisely
Journal:  Can J Psychiatry       Date:  2015-12       Impact factor: 4.356

5.  Comparing algorithms for deriving psychosis diagnoses from longitudinal administrative clinical records.

Authors:  Grant Sara; Luming Luo; Vaughan J Carr; Alessandra Raudino; Melissa J Green; Kristin R Laurens; Kimberlie Dean; Martin Cohen; Philip Burgess; Vera A Morgan
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-05-01       Impact factor: 4.328

6.  Antidepressants and fracture risk in older adults: a comparative safety analysis.

Authors:  J J Gagne; A R Patrick; H Mogun; D H Solomon
Journal:  Clin Pharmacol Ther       Date:  2011-04-20       Impact factor: 6.875

7.  Validity of the diagnosis of a single depressive episode in a case register.

Authors:  Camilla Bock; Jens Drachmann Bukh; Maj Vinberg; Ulrik Gether; Lars Vedel Kessing
Journal:  Clin Pract Epidemiol Ment Health       Date:  2009-02-12

8.  Antidepressant use and risk for preeclampsia.

Authors:  Kristin Palmsten; Krista F Huybrechts; Karin B Michels; Paige L Williams; Helen Mogun; Soko Setoguchi; Sonia Hernández-Díaz
Journal:  Epidemiology       Date:  2013-09       Impact factor: 4.822

9.  Health advisories and patterns of patient monitoring among new users of antidepressant medications.

Authors:  Joshua J Gagne; Amanda R Patrick; Philip S Wang; Sebastian Schneeweiss
Journal:  J Clin Psychopharmacol       Date:  2009-12       Impact factor: 3.153

10.  Data enhancement for co-morbidity measurement among patients referred for sleep diagnostic testing: an observational study.

Authors:  Paul E Ronksley; Willis H Tsai; Hude Quan; Peter Faris; Brenda R Hemmelgarn
Journal:  BMC Med Res Methodol       Date:  2009-07-15       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.